Concepedia

Amy Bunker

AB

Statistics

Publications

12

Citations

450

H-Index

11

Active since

1993

Affiliations

Pfizer (United States)(Current)

Bristol-Myers Squibb (United States)

Amy Bunker is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and pharmacy.

Publications per year

1993–2008

12

Publications

12

A mechanism for toxin insertion into membranes is suggested by the crystal structure of the channel-forming domain of colicin E1

P.A. Elkins, Amy Bunker, William Cramer et al. · Structure · 1997 · 132 citations · Full text

, , +14

Quinazolinones and Pyrido[3,4- <i>d</i> ]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis

Jie Jack Li, Joe Nahra, Adam R. Johnson et al. · Journal of Medicinal Chemistry · 2008 · 87 citations · Full text

, , +17

Rational Design, Synthesis, and Biological Activity of Benzoxazinones as Novel Factor Xa Inhibitors

Danette A. Dudley, Amy Bunker, Liguo Chi et al. · Journal of Medicinal Chemistry · 2000 · 49 citations · Full text

, , +17

Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors

Makonen Belema, Amy Bunker, Van N. Nguyen et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 34 citations · Full text

, , +11

Fused Pyrimidines. Part 5. Pyrimido[4,5-d]pyrimidine Analogues of Folic Acid

Thomas J. Delia, Thomas J. Delia, Markus Baumann et al. · Heterocycles · 1993 · 27 citations · Full text

, , +5

1–5 of 12